Literature DB >> 1560193

Expression of very late activation antigen-1 on intrathyroid lymphocytes in autoimmune thyroid disease.

F Paolieri1, G P Pesce, G C Torre, G W Canonica, M Bagnasco.   

Abstract

Very late activation antigen-1 (VLA-1) is a beta 1-integrin implied in interaction with extracellular matrix components. It is expressed by T lymphocytes upon prolonged activation in vitro. In this work we have evaluated VLA-1 expression in thyroid infiltrates and peripheral blood of patients with autoimmune thyroid disease (AITD), by immunofluorescence on dispersed cells and by in situ analysis on frozen tissue sections. The results obtained showed increased proportions of VLA-1 positive lymphocytes in thyroid infiltrates, similarly to that observed with "early" activation antigens. No positivity of thyroid follicular cells was observed. Given the role of the VLA-1 molecule in lymphocyte adhesion, the increased VLA-1 positivity of infiltrating lymphocytes is consistent with intrathyroidal homing of long-term activated cells, possibly relevant to AITD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560193     DOI: 10.1007/BF03348664

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

Review 1.  VLA proteins in the integrin family: structures, functions, and their role on leukocytes.

Authors:  M E Hemler
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  Lymphocyte extracellular matrix interactions. Induction of interferon by connective tissue components.

Authors:  W Ofosu-Appiah; R J Warrington; K Morgan; J A Wilkins
Journal:  Scand J Immunol       Date:  1989-05       Impact factor: 3.487

3.  CD16 surface molecules regulate the cytolytic function of CD3CD16+ human natural killer cells.

Authors:  A Moretta; G Tambussi; E Ciccone; D Pende; G Melioli; L Moretta
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

4.  Expression of intercellular adhesion molecule-1 (ICAM-1) on thyroid epithelial cells in Hashimoto's thyroiditis but not in Graves' disease or papillary thyroid cancer.

Authors:  M Bagnasco; A Caretto; D Olive; B Pedini; G W Canonica; C Betterle
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

5.  Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).

Authors:  J L Cordell; B Falini; W N Erber; A K Ghosh; Z Abdulaziz; S MacDonald; K A Pulford; H Stein; D Y Mason
Journal:  J Histochem Cytochem       Date:  1984-02       Impact factor: 2.479

6.  Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cells.

Authors:  A P Weetman; S Cohen; M W Makgoba; L K Borysiewicz
Journal:  J Endocrinol       Date:  1989-07       Impact factor: 4.286

7.  Expression of the VLA family of integrins in human intestine.

Authors:  M Y Choy; P I Richman; M A Horton; T T MacDonald
Journal:  J Pathol       Date:  1990-01       Impact factor: 7.996

8.  Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation.

Authors:  M E Hemler; D Glass; J S Coblyn; J G Jacobson
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

9.  Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells.

Authors:  G W Canonica; M Caria; G Torre; A Risso; M E Cosulich; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1984-12       Impact factor: 4.256

10.  Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production.

Authors:  M E Sanders; M W Makgoba; S O Sharrow; D Stephany; T A Springer; H A Young; S Shaw
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

View more
  1 in total

1.  Infiltrating gamma/delta T-cell receptor-positive lymphocytes in Hashimoto's thyroiditis, Graves' disease and papillary thyroid cancer.

Authors:  F Paolieri; C Pronzato; M Battifora; N Fiorino; G W Canonica; M Bagnasco
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.